Literature DB >> 8880075

5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats.

J L Moreau1, M Bös, F Jenck, J R Martin, P Mortas, J Wichmann.   

Abstract

Potential antidepressant properties of preferential 5HT2C receptor agonists were investigated in stress-induced anhedonia, a validated simulation of depression. This simulation evaluates the hedonic state of stressed rats by recording variations in self-stimulation threshold measured before, during, and after exposure to intermittent, unpredictable, mild stressors. This stress regimen gradually elevates self-stimulation threshold, suggesting the development of an anhedonic state. In stressed animals, chronic treatment with the preferential 5HT2C receptor agonists Ro 60-0175 and Ro 60-0332 (3 mg/kg i.p. b.i.d.) prevented the loss of sensitivity to reward. Similarly, when stressed anhedonic animals were curatively treated with Ro 60-0175 (3 mg/kg i.p. b.i.d.), the stress-induced anhedonia was gradually reversed. These results suggest a role for 5HT2C receptors in some aspects of depression, and potential antidepressant properties for selective 5HT2C receptor agonists. Such compounds may offer an innovative approach to the treatment of mood disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880075     DOI: 10.1016/0924-977x(96)00015-6

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  16 in total

1.  5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations.

Authors:  Jasminka Stefulj; Andreas Büttner; Milovan Kubat; Peter Zill; Melita Balija; Wolfgang Eisenmenger; Brigitta Bondy; Branimir Jernej
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-08       Impact factor: 5.270

Review 2.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

Review 3.  Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.

Authors:  C Sánchez; J Hyttel
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

4.  Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling.

Authors:  Marilyne Labasque; Eric Reiter; Carine Becamel; Joël Bockaert; Philippe Marin
Journal:  Mol Biol Cell       Date:  2008-09-03       Impact factor: 4.138

Review 5.  Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors:  Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal:  NeuroRx       Date:  2005-10

6.  S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Authors:  Anne Dekeyne; Clotilde Mannoury la Cour; Alain Gobert; Mauricette Brocco; Françoise Lejeune; Florence Serres; Trevor Sharp; Annie Daszuta; Amélie Soumier; Mariusz Papp; Jean-Michel Rivet; Gunnar Flik; Thomas I Cremers; Olivier Muller; Gilbert Lavielle; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-06-04       Impact factor: 4.530

7.  Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats.

Authors:  Dave J Hayes; Robert Clements; Andrew J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  2008-11-25       Impact factor: 4.530

8.  Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2.

Authors:  Minati Singh; M Bridget Zimmerman; Terry G Beltz; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2009-04-08

Review 9.  Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.

Authors:  Chi-Un Pae; Alessandro Serretti; Ashwin A Patkar; Praksh S Masand
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  An animal model of a behavioral intervention for depression.

Authors:  Daniela D Pollak; Francisco J Monje; Lee Zuckerman; Christine A Denny; Michael R Drew; Eric R Kandel
Journal:  Neuron       Date:  2008-10-09       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.